Is Herbal Supplement Kratom an Opioid? The FDA Says Yes

(WASHINGTON) — U.S. health authorities say an herbal supplement promoted as an alternative pain remedy contains the same chemicals found in opioids, the addictive family of drugs at the center of a national addiction crisis. The Food and Drug Administration analysis, published Tuesday, makes it more likely that the supplement, kratom, could be banned by the federal government. The FDA also said it has identified 44 reports of death involving kratom since 2011, up from 36 reported in November. Sold in various capsules and powders, kratom has gained popularity in the U.S. as a treatment for pain, anxiety and drug dependence. Proponents argue that the substance is safer than opioid painkillers like OxyContin and Vicodin, which have contributed to an epidemic of drug abuse. More than 63,000 Americans died in 2016 from drug overdoses, mostly from opioids. FDA Commissioner Scott Gottlieb reiterated that there are no FDA-approved medical uses for kratom, which is derived from a plant native to Southeast Asia. “Claiming that kratom is benign because it’s ‘just a plant’ is shortsighted and dangerous,” Gottlieb said in a statement. “It’s an opioid. And it’s an opioid that’s associated with novel risks because of the variability in how it’s being formulated, sold and used recreationally.” FDA scientists analyzed the 25 most common chemical compounds in kratom and concluded that they behave like those found in opio...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized Addiction APH healthytime onetime Source Type: news

Related Links:

We describe the effects of drug exposure during development, implications for understanding psychosis and cannabis use disorder, and methodological considerations. Greater understanding of the precise mechanisms underlying the effects of cannabis may also give rise to new treatment targets.
Source: Pharmacology and Therapeutics - Category: Drugs & Pharmacology Source Type: research
In this study, eutectic mixtures, as binary pharmaceutical compositions of CEL with adipic acid (ADI) and saccharin (SAC), were identified through a phase diagram and Tammann’s triangle intended to improve the wettability and dissolution rate of poorly water-soluble CEL. The contact angles at 0s in the liquid-solid interface were approximately θs (theta) 79.7° ± 0.50° and 86.65° ± 0.45° for CEL-ADI and CEL-SAC, respectively, which were much lower than the value obtained for CEL (92.05° ± 0.75° θ). Moreover, a comparison of the disk intrinsic dissolution rate an...
Source: International Journal of Pharmaceutics - Category: Drugs & Pharmacology Source Type: research
ConclusionMost potent three chemicals (ZA-2, 6 and 7) could be considered as bioactive to ensure the robust quality of the enriched fraction of ZAF with defined XO inhibition potential. Therefore, either single purified component or their enriched fraction could be a better choice for the management of gout than the crude extract of ZAF. Developed HPLC method is suitable for quality assurance analysis and process control of ZAF derived product intended for gout management. XO inhibitory potential exhibited by the characterized compounds validate the traditional use of this ZAF for the treatment of gout. Further, a detailed...
Source: Journal of Ethnopharmacology - Category: Drugs & Pharmacology Source Type: research
Publication date: Available online 19 October 2018Source: Anaesthesia Critical Care &Pain MedicineAuthor(s): Eric Kipnis, Marc Leone
Source: Anaesthesia, Critical Care and Pain Medicine - Category: Anesthesiology Source Type: research
Publication date: Available online 19 October 2018Source: Anaesthesia Critical Care &Pain MedicineAuthor(s): Miet Schetz, Matthieu Legrand
Source: Anaesthesia, Critical Care and Pain Medicine - Category: Anesthesiology Source Type: research
Publication date: Available online 19 October 2018Source: Anaesthesia Critical Care &Pain MedicineAuthor(s): Robin Florian, Guen Morgan Le
Source: Anaesthesia, Critical Care and Pain Medicine - Category: Anesthesiology Source Type: research
Publication date: Available online 19 October 2018Source: Anaesthesia Critical Care &Pain MedicineAuthor(s): Guinot Pierre-Grégoire
Source: Anaesthesia, Critical Care and Pain Medicine - Category: Anesthesiology Source Type: research
Publication date: Available online 19 October 2018Source: Anaesthesia Critical Care &Pain MedicineAuthor(s): Armelle Nicolas-Robin
Source: Anaesthesia, Critical Care and Pain Medicine - Category: Anesthesiology Source Type: research
WASHINGTON (AP) — U.S. health authorities say an herbal supplement promoted as an alternative pain remedy contains the same chemicals found in opioids, the addictive family of drugs at the center of a national addiction crisis. The Food and Drug Administration analysis, published Tuesday, makes it more likely that the supplement, kratom, could be banned by the federal government. The FDA also said it has identified 44 reports of death involving kratom since 2011, up from 36 reported in November. Sold in various capsules and powders, kratom has gained popularity in the U.S. as a treatment for pain, anxiety and drug de...
Source: JEMS Patient Care - Category: Emergency Medicine Authors: Tags: Patient Care News Source Type: news
More News: Addiction | Anxiety | Chemistry | Complementary Medicine | Epidemics | Epidemiology | Food and Drug Administration (FDA) | Government | Health | Herbs | Hydrocodone | Legislation | Lortab | Morphine | Myopia (short sighted) | Overdose | Oxycodone | OxyContin | Pain | Politics | Substance Abuse | Vicodin